Clinical Trials · NCT06577090

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

Name: Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Active Not RecruitingPhase 2Semaglutide

Phase: Phase 2
Recruitment status: Active Not Recruiting
Sponsor: Skye Bioscience, Inc.
Enrollment: 136
Start date: Aug 2024
Locations: 16 sites, United States
Primary endpoint: Percent change in body weight (main study)

View Semaglutide compound reference